From: Diagnosis of cutaneous sarcoidosis; clinical and the prognostic significance of skin lesions
Type of lesion | N. of patients (%) | Age (mean ± SD) | N. (%) of female patients |
---|---|---|---|
Erythema nodosum | 25 (20.8%) | 38.6 ± 8.4 | 19 (15.8%) |
Lupus Pernio | 21 (17.5%) | 41.8 ± 9.2 | 12 (10%) |
Maculopapular lesions | 19 (15.8%) | 40.3 ± 7.1 | 14 (11.6%) |
Plaque | 14 (11.6%) | 42.6 ± 6.2 | 9 (7.5%) |
Nodules | 10 (8.3%) | 36.9 ± 10.4 | 6 (5%) |
Scar | 8 (6.6%) | 39.4 ± 5.3 | 7 (5.8%) |
Verrucose outgrowths | 7 (5.8%) | 44.9 ± 14.1 | 5 (4.1%) |
Subcutaneous lesions | 6 (5%) | 37.4 ± 11.2 | 3 (2.5%) |
Ulcerative and vesicular lesions | 5 (4.1%) | 42.6 ± 8.3 | 3 (2.5%) |
Ichthyosis | 3 (2.5%) | 39.4 ± 3.9 | 2 (1.6%) |
Erythema multiforme | 2 (1.6%) | 38 ± 5.6 | 2 (1.6%) |